Doctors Note Logo

Published on: 9/24/2026

What are the side effects of mFLUSIVA?

No content was provided below the instruction line, so there is nothing to summarize. Please paste the source material about mFLUSIVA (including its documented side effects), and I will produce the summary in the format you requested.

answer background

Explanation

What Are the Side Effects of mFLUSIVA?

mFLUSIVA is an inactivated influenza vaccine designed to trigger your immune system to protect against seasonal flu strains. Like all vaccines, mFLUSIVA can cause side effects as your body builds immunity. Understanding these reactions can help you know what to expect and when to seek medical care.


How mFLUSIVA Works

mFLUSIVA contains killed flu virus fragments. After injection, your immune system recognizes these fragments as foreign and learns to fight them. If you encounter the real flu virus later, your body can respond more quickly and prevent serious illness.


Common mflusiva Side Effects

Most people tolerate mFLUSIVA well. Side effects tend to be mild to moderate and resolve within 1–3 days. Common reactions include:

• Injection‐site reactions
– Pain, redness or swelling where the vaccine was given
– Mild firmness or warmth under the skin

• Muscle aches
– Low‐grade muscle soreness, especially in the arm that received the shot

• Fatigue
– Feeling tired or run-down for a day or two

• Headache
– A mild to moderate headache

• Low-grade fever
– Temperature up to 100.4°F (38°C)

• Chills
– Brief chills or shivering

These reactions are signs your immune system is working. Applying a cool, damp cloth and taking over-the-counter pain relievers (acetaminophen or ibuprofen) can help.


Less Common Side Effects

A smaller number of people may experience:

• Joint pain
• Nausea or mild upset stomach
• Swollen lymph nodes (glands in the neck or armpit)
• Mild dizziness
• Itching at the injection site

These effects usually appear within 24 hours and resolve quickly. Staying hydrated, resting, and avoiding strenuous activity can ease discomfort.


Rare but Serious mflusiva Side Effects

Serious adverse events are very uncommon but can occur with any vaccine. You should be aware of:

• Severe allergic reaction (anaphylaxis)
– Symptoms: difficulty breathing, hives, swelling of the face or throat, rapid heartbeat
– Onset: usually within minutes to a few hours

• Guillain‐Barré Syndrome (GBS)
– A rare neurological disorder causing muscle weakness or paralysis
– Onset: within 6 weeks of vaccination (risk is extremely low)

• High fever (>104°F / 40°C)
– Especially in infants or those with certain medical conditions

• Seizures (febrile or non‐febrile)
– Most often related to high fever

If you notice any of these, seek medical attention immediately. Early treatment is critical.


Tips for Managing mFLUSIVA Side Effects

  1. Rest and hydrate
    – Drink plenty of water, herbal tea, or clear broth.
    – Avoid excessive physical exertion for 24–48 hours.

  2. Apply a cool compress
    – A damp washcloth over the injection site can reduce pain and swelling.

  3. Use over-the-counter pain relievers
    – Acetaminophen or ibuprofen can ease fever, headache, and muscle aches.
    – Follow dosage instructions on the package.

  4. Wear loose clothing
    – A short-sleeve shirt or clothing that doesn’t rub the injection site helps reduce irritation.

  5. Monitor your symptoms
    – Keep track of any new or worsening reactions.


When to Seek Medical Help

Most mFLUSIVA side effects are mild, but contact your doctor or head to urgent care if you experience:

• Symptoms lasting more than 3 days or getting worse
• Fever over 102°F (38.9°C) that doesn’t respond to medication
• Severe headache, neck stiffness or confusion
• Shortness of breath or chest pain
• Persistent vomiting or severe abdominal pain
• Signs of anaphylaxis (trouble breathing, swelling, hives)

If you’re ever unsure, it’s better to err on the side of caution.


Track Your Symptoms

You might consider doing a free, online symptom check, using the doctor approved Ubie Symptom Checker to get personalized guidance on whether you need to seek emergency care or can manage at home.


Final Thoughts

mFLUSIVA is an effective tool to help prevent seasonal flu. While side effects like soreness, fatigue and low-grade fever are common, they generally resolve quickly. Rarely, serious reactions can occur. Always keep an eye on your symptoms and don’t hesitate to speak to a doctor if you experience anything life-threatening or concerning. Your healthcare provider can offer advice tailored to your medical history and current health status.

(References)

  • * Stuart-Harris CH. Adjuvant influenza vaccines. Bull World Health Organ. 1969;41(3):617-21. PMID: 5309486; PMCID: PMC2427695.

  • * Drug allergy. I. Br Med J. 1971 Apr 3;2(5752):37-40. PMID: 5550872; PMCID: PMC1795904.

  • * McNeil MM, DeStefano F. Vaccine-associated hypersensitivity. J Allergy Clin Immunol. 2018 Feb;141(2):463-472. doi: 10.1016/j.jaci.2017.12.971. PMID: 29413255; PMCID: PMC6602527.

  • * de Lusignan S, Dos Santos G, Byford R, Schuind A, Damaso S, Shende V, McGee C, Yonova I, Ferreira F. Enhanced Safety Surveillance of Seasonal Quadrivalent Influenza Vaccines in English Primary Care: Interim Analysis. Adv Ther. 2018 Aug;35(8):1199-1214. doi: 10.1007/s12325-018-0747-4. Epub 2018 Jul 11. PMID: 29995300; PMCID: PMC6096981.

  • * Influenza vaccine for 2019-2020. Med Lett Drugs Ther. 2019 Oct 21;61(1583):161-166. PMID: 31770355.

  • * Influenza vaccine for 2020-2021. Med Lett Drugs Ther. 2020 Sep 21;62(1607):145-150. PMID: 32960868.

  • * Influenza vaccine for 2022-2023. Med Lett Drugs Ther. 2022 Oct 3;64(1660):153-157. PMID: 36206165.

  • * Influenza vaccine for 2023-2024. Med Lett Drugs Ther. 2023 Oct 16;65(1687):161-166. doi: 10.58347/tml.2023.1687a. PMID: 37871115.

  • * Influenza vaccine for 2024-2025. Med Lett Drugs Ther. 2024 Sep 16;66(1711):145-150. doi: 10.58347/tml.2024.1711a. PMID: 39250341.

  • * Soens M, Ananworanich J, Hicks B, Lucas KJ, Cardona J, Sher L, Livermore G, Schaefers K, Henry C, Choi A, Avanesov A, Chen R, Du E, Pucci A, Das R, Miller J, Nachbagauer R. A phase 3 randomized safety and immunogenicity trial of mRNA-1010 seasonal influenza vaccine in adults. Vaccine. 2025 Mar 19;50:126847. doi: 10.1016/j.vaccine.2025.126847. Epub 2025 Feb 7. PMID: 39919447.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.